Publication details
Klinická studie ScrePAN
| Title in English | ScrePAN clinical trial |
|---|---|
| Authors | |
| Year of publication | 2024 |
| Type | Article in Periodical |
| Magazine / Source | Florence |
| MU Faculty or unit | |
| Citation | |
| Web | ScrePAN |
| Keywords | pancreatic adenocarcinoma; cancer illnesses; Clinical study; ScrePAN |
| Description | Pancreatic carcinoma (CaP) is assocd with an extremely poor prognosis from several reasons. It is usually diagnosed in an advanced stage stage, which is often asymptomatic during the course of the disease or non-specific symptoms (feeling of bloating, food does not make me feel well, feeling heavy, indigestion, alternating constipation, diarrhea) and deficiency sensitive and specific tumor markers. The prognosis of this disease is poor also due to limited screening options and curative interventions for a short "lead time" in rapidly metastasizing disease. |